Showing results (221-230 of 229) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Current Neuropharmacology|January 15, 2025
Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study GroupGianluca Rosso, Giacomo d'Andrea, Stefano Barlati, et al.Journal of Affective Disorders|December 25, 2023
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world dataGiacomo d'Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, et al.Journal of Personalized Medicine|September 23, 2022
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case ReportsMatteo Marcatili, Riccardo Borgonovo, Noemi Cimminiello, et al.Bipolar Disorders|January 13, 2023
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depressionGiovanni Martinotti, Bernardo Dell'Osso, Giorgio Di Lorenzo, et al.Psychiatry Research|August 27, 2025
Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study groupGiacomo d'Andrea, Clara Cavallotto, Mauro Pettorruso, et al.Psychiatry Research|August 13, 2023
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)Mauro Pettorruso, Roberto Guidotti, Giacomo d'Andrea, et al.Rivista Di Psichiatria|April 17, 2025
[Assisted suicide for patients suffering from severe depression. An unacceptable option that psychiatrists must fight with all their strength.]Giovanni de Girolamo, Andrea Angelozzi, Anna Rita Atti, et al.Journal of Personalized Medicine|April 25, 2025
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience)Marco Di Nicola, Maria Pepe, Giacomo d'Andrea, et al.Journal of Affective Disorders|September 27, 2022
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)Giovanni Martinotti, Antonio Vita, Andrea Fagiolini, et al.Pageof 23